Please login to the form below

Not currently logged in

PRA opens Beijing office to expand Chinese operations

New office adds to the CRO's existing base in Shanghai

PRA has expanded its operations in China and opened a new office in Beijing to expand its presence in the country and add to its existing Shanghai office.

The move caps an already busy year for the US-based contract research organisation (CRO), which has so far opened new offices in the UK, the Netherlands and Singapore during 2012.

Helen Neal, regional director – clinical operations, Asia Pacific, Middle East, and North Africa, said: “As the demand for clinical sites in Asia increase, we continually strive to strengthen our existing operations in China and the Asia Pacific region. 

“By adding more professional staff and locations, we can give our clients greater access to these critical markets and geography. In addition to our expansion in China, we continue to increase our presence into new and emerging South East Asian regions for access to patients and resources.”

The company said the move would particularly help it boost local project teams' ability to meet the growing demand for clinical drug development programmes.

Kent Thoelke, executive VP of scientific and medical affairs, said: “In order for global drug development to continue successfully, the need to access patients at high-quality ICH/GCP sites in emerging regions like China is critical.

“PRA's expansion in this market gives us the ability to bring exciting new clinical trials to a much broader market in China, while providing even greater patient access to our clients and sponsor companies.”

PRA has been operating in China for over 10 years. In addition to an office in Hong Kong, the CRO also has Asia Pacific bases in countries such as South Korea, Taiwan, Thailand, Singapore, Australia, New Zealand, and India.

29th August 2012

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Atlantis Healthcare

Atlantis Healthcare creates and executes Health Psychology–based treatment adherence programs for global pharmaceutical companies across a wide range of diseases....

Latest intelligence

What is a patient-centric brand anyway?
It’s hard to believe that in our industry, there have been ongoing rumblings about patient-centricity for years now. Sure, there are some great companies who have worked hard to bring...
‘Less Is More: Making Patient-Centered Digital Communication a Reality’
Letizia Affinito writes on the Gower Publishing blog....
The Seven Cs Of Cross-Functional Brand Planning
As more and more organisations have moved to cross-functional and cross-regional involvement in the development of their strategic and operational brand plans, the result has been greater engagement and alignment,...